Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-5825.34%
operating margin TTM
-1233.59%
revenue TTM
4.61 Million
revenue per share TTM
0.13$
valuation ratios | |
|---|---|
| pe ratio | -1.06 |
| peg ratio | 0.01 |
| price to book ratio | -0.89 |
| price to sales ratio | 62.32 |
| enterprise value multiple | 0.50 |
| price fair value | -0.89 |
profitability ratios | |
|---|---|
| gross profit margin | 68.23% |
| operating profit margin | -1233.59% |
| pretax profit margin | -5825.34% |
| net profit margin | -5825.34% |
| return on assets | -213.65% |
| return on equity | 89.7% |
| return on capital employed | 25.4% |
liquidity ratios | |
|---|---|
| current ratio | 0.11 |
| quick ratio | 0.11 |
| cash ratio | 0.10 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 280.14 |
| days of payables outstanding | 415.50 |
| cash conversion cycle | -135.36 |
| receivables turnover | 1.30 |
| payables turnover | 0.88 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 3.49 |
| debt equity ratio | -1.36 |
| long term debt to capitalization | -0.22 |
| total debt to capitalization | 3.79 |
| interest coverage | -1.90 |
| cash flow to debt ratio | -0.08 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.70 |
| cash per share | 0.65 |
| operating cash flow per share | -0.69 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -0.08 |
| short term coverage ratios | -0.10 |
| capital expenditure coverage ratio | -67.97 |
Frequently Asked Questions
When was the last time Armata Pharmaceuticals, Inc. (AMEX:ARMP) reported earnings?
Armata Pharmaceuticals, Inc. (ARMP) published its most recent earnings results on 12-08-2026.
What is Armata Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Armata Pharmaceuticals, Inc. (AMEX:ARMP)'s trailing twelve months ROE is 89.7%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Armata Pharmaceuticals, Inc. (ARMP) currently has a ROA of -213.65%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ARMP's net profit margin stand at?
ARMP reported a profit margin of -5825.34% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ARMP's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.11 in the most recent quarter. The quick ratio stood at 0.11, with a Debt/Eq ratio of -1.36.